Invitae Saham

Invitae Margin OCF

Delisted·7 Agu 2024

Margin Arus Kas Operasional dari Invitae (NVTAQ) pada 13 Agu 2026 adalah -48,92 %. Tahun sebelumnya, Margin Arus Kas Operasional adalah -95,48 % — perubahan sebesar -48,77% (lebih tinggi).

Margin OCF

-48,92 %

YoY

-48,77%

Terakhir Diperbarui:

Margin Arus Kas Operasional dari Invitae adalah 2026 -48,92 % . Margin Arus Kas Operasional dari Invitae adalah 2025 -95,48 % . Menurun -48,77% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Invitae Analisis saham

Apa yang dilakukan Invitae? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Invitae

Margin Arus Kas Operasional Invitae adalah -48,92 % pada tahun 2026.

Margin Arus Kas Operasional dari Invitae berubah dari -95,48 % menjadi -48,92 %, mewakili perubahan -48,77%. Nilainya lebih tinggi daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Margin Arus Kas Operasional Invitae sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Margin OCF mengukur persentase pendapatan yang dikonversi menjadi arus kas operasional. Ini menunjukkan efisiensi generasi kas dari operasi bisnis inti.

Nilai '' yang 'baik' bervariasi menurut industri dan tahap perusahaan. Di Eulerpool, Anda dapat membandingkan Invitae Margin Arus Kas Operasional dengan pesaing sektor dan rata-rata industri untuk menilai apakah menarik.

Untuk mengevaluasi Margin Arus Kas Operasional, sangat penting untuk membandingkannya dengan perusahaan sejenis di industri dan sektor yang sama. Di Eulerpool, Anda dapat menemukan perbandingan industri langsung untuk Margin Arus Kas Operasional.

Access this data via the Eulerpool API

Margin — Invitae

Semua Metrik Kunci — Invitae